Abstract:Preeclampsia, one of the most enigmatic complications of pregnancy, is considered a pregnancy-specific disorder caused by the placenta and cured only by delivery. This article traces the condition from its origins-once thought to be a disease of the central nervous system, recognized by the occurrence of seizures (ie, eclampsia)-to the present time when preeclampsia is conceptualized primarily as a vascular disorder. We review the epidemiologic data that led to the recommendation to use diastolic hypertension and proteinuria as diagnostic criteria, as their combined presence was associated with an increased risk of fetal death and the birth of small-for-gestational-age neonates. However, preeclampsia is a multisystemic disorder with protean manifestations, and the condition can be present even in the absence of hypertension and proteinuria. Toxins gaining access to the maternal circulation have been proposed to mediate the clinical manifestations-hence, the term "toxemia of pregnancy," which was used for several decades. The search for putative toxins has challenged investigators for more than a century, and a growing body of evidence suggests that products of an ischemic or a stressed placenta are responsible for the vascular changes that characterize this syndrome. The discovery that the placenta can produce antiangiogenic factors, which regulate endothelial cell function and induce intravascular inflammation, has been a major step forward in the understanding of preeclampsia. We view the release of antiangiogenic factors by the placenta as an adaptive response to improve uterine perfusion by modulating endothelial function and maternal cardiovascular performance. However, this homeostatic response can become maladaptive and lead to damage of target organs during pregnancy or the postpartum period. Early-onset preeclampsia has many features in common with atherosclerosis, whereas late-onset preeclampsia seems to result from a mismatch of fetal demands and maternal supply, that is, a metabolic crisis. Preeclampsia, as it is understood today, is essentially vascular dysfunction unmasked or caused by pregnancy. A subset of patients diagnosed with preeclampsia are at greater risk of the subsequent development of hypertension, ischemic heart disease, heart failure, vascular dementia, and end-stage renal disease. However, these adverse events may be the result of a preexisting vascular pathologic process; it is not known if the occurrence of preeclampsia increases the baseline risk. Therefore, the understanding, prediction, prevention, and treatment of preeclampsia are healthcare priorities.

Preeclampsia - A patient's perspective

The Preeclampsia Foundation: the voice and views of the patient and her family

The Feto-Maternal Outcomes and Incidence of Early-and Late-Onset Preeclampsia

Eclampsia or epilepsy? The intriguing experiences of pregnant women diagnosed with preeclampsia and eclampsia: A descriptive exploratory study

Preeclampsia-Pathophysiology and Clinical Presentations: JACC State-of-the-Art Review

Postpartum Preeclampsia: What Can Stories Posted on the Internet Tell Us?

#Preeclampsiasurvivor and symbolic interactionism in women's maternal health

Preeclampsia: Platelet procoagulant membrane dynamics and critical biomarkers

Patient journey during and after a pre-eclampsia-complicated pregnancy: a cross-sectional patient registry study

Preeclampsia: A comprehensive review

Preeclampsia; short and long-term consequences for mother and neonate

Preeclampsia: Risk Factors, Diagnosis, Management, and the Cardiovascular Impact on the Offspring

Preeclampsia: a report and recommendations of the workshop of the Society for Maternal-Fetal Medicine and the Preeclampsia Foundation

'I don't really understand this BP': Women's knowledge, attitudes, and experiences with preeclampsia in Ghana

Preeclampsia and eclampsia: the conceptual evolution of a syndrome

Gene therapy in preeclampsia: the dawn of a new era

Preeclampsia beyond pregnancy: long-term consequences for mother and child

Pre-Eclampsia: Re-visiting Pathophysiology, Role of immune cells in Pre-Eclampsia, Biomarker identification and recent advances in its Management

Preeclampsia’s Cardiovascular Aftermath: A Comprehensive Review of Consequences for Mother and Offspring

Pre-eclampsia and the foetus: a cardiovascular perspective

New Ideas for the Prevention and Treatment of Preeclampsia and Their Molecular Inspirations